WuXi Biologics (Cayman) Inc. WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.

2269

Rank in Stocks #991
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Share Price
$5.74
Market Cap
$23.64B
Change (1 day)
-8.79%
Change (1 year)
24.58%
Country
CN
Trade WuXi Biologics (Cayman) Inc. (2269)

Category

Healthcare
Stock split history for WuXi Biologics (Cayman) Inc. (2269)
WuXi Biologics (Cayman) Inc. stock (symbol: 2269) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 22, 2026.
One 2269 share bought prior to Oct 22, 2026 would equal to 0 2269 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
US
1 x3
AU
0 -
NL
0 -
CH